Macquarie Group
TNDM icon

Macquarie Group’s Tandem Diabetes Care TNDM Stock Holding History

Macquarie Group’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-83,756
Closed -$3.38M – 1892
2024
Q2 		$3.38M Buy
+83,756
New +$3.49M ﹤0.01% 1072
2023
Q4 		– Sell
-57,969
Closed -$1.2M – 1684
2023
Q3 		$1.2M Buy
57,969
+16,135
+39% +$443K ﹤0.01% 1301
2023
Q2 		$1.03M Buy
41,834
+6,390
+18% +$206K ﹤0.01% 1351
2023
Q1 		$1.44M Sell
35,444
-293,280
-89% -$12.1M ﹤0.01% 1268
2022
Q4 		$14.8M Sell
328,724
-116,502
-26% -$5.27M 0.02% 757
2022
Q3 		$21.3M Sell
445,226
-216,264
-33% -$11.9M 0.03% 668
2022
Q2 		$39.2M Sell
661,490
-10,251
-2% -$842K 0.04% 546
2022
Q1 		$78.1K Sell
671,741
-287,288
-30% -$33.5M 0.06% 377
2021
Q4 		$144M Buy
959,029
+8,649
+0.9% +$1.17M 0.12% 220
2021
Q3 		$113M Buy
950,380
+6,847
+0.7% +$754K 0.1% 267
2021
Q2 		$91.9M Buy
943,533
+887,777
+1,592% +$79.2M 0.08% 326
2021
Q1 		$4.92M Sell
55,756
-250,948
-82% -$23.3M 0.01% 913
2020
Q4 		$29.3M Buy
306,704
+201,769
+192% +$20.8M 0.04% 424
2020
Q3 		$11.9M Sell
104,935
-3,501
-3% -$368K 0.02% 602
2020
Q2 		$10.7M Buy
108,436
+4,666
+4% +$372K 0.02% 615
2020
Q1 		$6.68M Hold
103,770
– – 0.01% 650
2019
Q4 		$6.18M Sell
103,770
-10,311
-9% -$636K 0.01% 753
2019
Q3 		$6.73M Hold
114,081
– – 0.01% 694
2019
Q2 		$7.36M Hold
114,081
– – 0.01% 680
2019
Q1 		$7.24M Buy
114,081
+2,541
+2% +$133K 0.01% 693
2018
Q4 		$4.24M Buy
111,540
+111,040
+22,208% +$3.92M 0.01% 787
2018
Q3 		$21K Sell
500
-18,700
-97% -$653K ﹤0.01% 1898
2018
Q2 		$423K Buy
+19,200
New +$236K ﹤0.01% 1417

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macquarie Group's TNDM Position: Q3 2024 in Review

Macquarie Group sold out of Tandem Diabetes Care (TNDM) in Q3 2024, closing a stake of 83,756 shares — an estimated $3.38M sold.

Macquarie Group first reported a position in TNDM in Q2 2018 and held it in 23 quarters. The position peaked at $144M in Q4 2021. 332 funds tracked by Wall St. Rank hold TNDM as of Q3 2024.

  • Macquarie Group reported no remaining Tandem Diabetes Care position as of Q3 2024 after selling out during the quarter.
  • Macquarie Group sold 83,756 Tandem Diabetes Care shares in Q3 2024, an estimated $3.38M.
  • Macquarie Group first reported a position in Tandem Diabetes Care in Q2 2018 and held it in 23 quarters.
  • Macquarie Group's Tandem Diabetes Care position peaked at $144M in Q4 2021.
  • 332 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2024.

Based on Macquarie Group's 13F filing for Q3 2024, filed 14 Nov 2024.